Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
코로나바이러스 질병 2019 메신저 RNA 백신 면역억제된 개인의 면역원성
Article
[키워드] 19 vaccine
2
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
addition
antibody
Antibody Response
Antibody responses
binding
CD4
CD8 T-cell
coronavirus
coronavirus disease
Coronavirus disease 2019
CoV
COVID
COVID-19
COVID-19 mRNA Vaccination
cross-reactivity
function
Immunocompromised
immunocompromised individuals
immunogenicity
immunosuppressive
increased mortality
individual
individuals
Infection
interferon
interferon-γ
lead
messenger
Messenger RNA
mRNA
mRNA vaccination
mRNA vaccine
Neutralizing
reduce
reduced
regimen
respiratory
response
RNA
SARS
SARS-CoV-2
SARS-CoV-2 variants
severe acute respiratory syndrome Coronavirus
T cells
therapy
These data
vaccine immunogenicity
Viral
viral clearance
Viral variants
[DOI] 10.1093/infdis/jiab569 PMC 바로가기 [Article Type] Article
[DOI] 10.1093/infdis/jiab569 PMC 바로가기 [Article Type] Article